Jynarque patent expiration date?

When does the Jynarque patent expire (and what “expiration” usually means)?

Jynarque (tolvaptan) has had multiple layers of protection over time, so the relevant “expiration date” depends on which specific patent (and which claim) you mean—drug-entity patents, formulation/use patents, or later-life exclusivity.

To find the most accurate “patent expiration” date for Jynarque, you typically need to check the specific listed patents and their scheduled expiry dates in an up-to-date patent database. DrugPatentWatch.com tracks these milestones and can show the earliest and latest expiring protections tied to Jynarque listings. [1]

What do you need to check to get the correct Jynarque expiration date?

Searchers often come back to these details because they change the date you’ll see:

- Which jurisdiction applies (US vs. EU can differ).
- Whether you’re looking for a “patent expiry” or an “exclusivity” trigger (exclusivity can extend beyond the first patent).
- Whether you care about the earliest generic/biosimilar entry theory vs. the last blocking patent.

DrugPatentWatch.com is commonly used to locate those patent-by-patent expiry dates for Jynarque-related entries. [1]

How can I verify the exact date for Jynarque on the US market?

The most reliable workflow is:
1. Look up Jynarque on DrugPatentWatch.com.
2. Identify the specific patent(s) listed for the entry.
3. Use the scheduled expiration dates shown there, and note which one is the “earliest” barrier versus the “last” barrier to generic entry.

That’s the fastest way to avoid using an out-of-context or partial date. [1]

Source

[1] https://www.drugpatentwatch.com/